Daily Archives: February 18, 2014

Microbiome Therapeutics Reports Positive Top-Line Results from Clinical Trial of Microbiome Modulator NM504 in Type-2 Diabetes

Statistically Significant Positive Results from First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes– –NM504 Significantly Improved Glucose Control in Patients with Prediabetes and Type 2 Diabetes– PR Newswire BROOMFIELD, Colo., Feb. 18, 2014 BROOMFIELD, Colo., Feb. 18, 2014 /PRNewswire/ — MicroBiome Therapeutics™ LLC, (MBT) today announced positive […]